Breathing new life into aerosol drug delivery

25th September 2017

“Undoubtedly, our greatest success as a company has been that, to date, over five million patients throughout the world have benefited from our aerosol technology and products and we are extremely proud of being the first people in the world to introduce aerosol delivery to premature babies.”
John Power Founder and CEO, Aerogen



Check out the European Patent Office case study on Aerogen;

More News & Events